
India · Hospital & health care startup
Niramai Health Analytix is a deep-tech healthcare company based in Bengaluru, India, focused on early breast cancer detection.
Funding reportedLast round: Non equity assistance
Follow Niramai Health Analytix and see its new rounds in your feed.Start following
Niramai Health Analytix is a deep-tech healthcare company based in Bengaluru, India, focused on early breast cancer detection.
The company has developed a novel, radiation-free, non-touch medical device called Thermalytix, which uses AI to identify breast cancer at earlier stages than traditional methods. Founded in July 2016 by Dr. Geetha Manjunath and Ms. Nidhi Mathur, Niramai aims to provide non-invasive solutions that help reduce mortality rates through early diagnosis. Niramai offers several services, including a home breast screening service conducted by trained female technicians and a free breast health helpline via WhatsApp. The company also provides "Easy Launch Kits" for NGOs and hospitals to facilitate affordable screening in underserved areas. Recognized as the most awarded health-tech startup in India, Niramai has received Series A funding and collaborates with various organizations to promote breast health awareness and screening globally.
Funding, as reported
From Niramai Health Analytix's own website: 1 founder, 4 on the team.
What they build
Known for
health caresponsorship for screeningspatented ai algorithmshealth equitywomen's healthmachine intelligencedistributionempowering womenenterprisesthermalytixbiomedical technologywomen's cancer detectionthermal image classificationblood vessel pattern analysisautomated breast screeninginformation technology & services
Built with from their website
Google MapsAmazon SESGoogle Tag ManagerContact Form 7LiteSpeedWordPress.orgHostinger CDNFont AwesomeYouTubeGoogle Workspace
Viewport MetaCookieYesDocSendAmazon Simple Email ServiceAIGoogle MeetRedux FrameworkPriority Hints
Add your raise, your deck and your story, and put Niramai Health Analytix in front of investors. Or tell us what we have wrong.